| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-065X.1994.TB00850.X |
| P698 | PubMed publication ID | 8070813 |
| P2093 | author name string | Roos D | |
| P2860 | cites work | Combination of arachidonic acid and guanosine 5'-O-(3-thiotriphosphate) induce translocation of rac p21s to membrane and activation of NADPH oxidase in a cell-free system | Q70472844 |
| Critical assessment of the presence of an NADPH binding site on neutrophil cytochrome b558 by photoaffinity and immunochemical labeling | Q72908801 | ||
| Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins | Q28269651 | ||
| The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex | Q28301409 | ||
| The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245 | Q28301419 | ||
| Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox gene | Q33205808 | ||
| Requirement for posttranslational processing of Rac GTP-binding proteins for activation of human neutrophil NADPH oxidase | Q34435975 | ||
| Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease | Q37822922 | ||
| Molecular genetics of chronic granulomatous disease | Q38252555 | ||
| NIH conference. Recent advances in chronic granulomatous disease | Q40115915 | ||
| Chronic granulomatous disease: the solving of a clinical riddle at the molecular level | Q40910517 | ||
| Functional activity of enucleated human polymorphonuclear leukocytes | Q41419454 | ||
| The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct | Q41578685 | ||
| Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays | Q41594655 | ||
| Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes | Q41619617 | ||
| Localization of the 47 kDa phosphoprotein involved in the respiratory-burst NADPH oxidase of phagocytic cells | Q41817828 | ||
| Identification of a superoxide-generating NADPH oxidase system in human fibroblasts | Q41823932 | ||
| Phosphorylation of the subunits of cytochrome b-245 upon triggering of the respiratory burst of human neutrophils and macrophages | Q42088807 | ||
| Oxidation-reduction properties of the cytochrome b found in the plasma-membrane fraction of human neutrophils. A possible oxidase in the respiratory burst | Q42180985 | ||
| Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein | Q43689162 | ||
| Cell-free translocation of recombinant p47-phox, a component of the neutrophil NADPH oxidase: effects of guanosine 5'-O-(3-thiotriphosphate), diacylglycerol, and an anionic amphiphile | Q44458073 | ||
| Characterization of a phagocyte cytochrome b558 91-kilodalton subunit functional domain: identification of peptide sequence and amino acids essential for activity | Q44493345 | ||
| Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 | Q59053220 | ||
| The management of chronic granulomatous disease | Q59512403 | ||
| Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype | Q68505557 | ||
| Activation by gamma interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased Km of the superoxide-generating NADPH oxidase | Q70117485 | ||
| A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b, and flavoprotein | Q70140378 | ||
| Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry | Q70177655 | ||
| Gamma interferon is able to enhance the oxidative metabolism of human neutrophils | Q70304842 | ||
| Generation of superoxide by purified and relipidated cytochrome b559 in the absence of cytosolic activators | Q70466332 | ||
| P304 | page(s) | 121-157 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | The genetic basis of chronic granulomatous disease | |
| P478 | volume | 138 |
| Q24679525 | 156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox |
| Q71867159 | A 15-base pair (bp) palindromic insertion associated with a 3-bp deletion in exon 10 of the gp91-phox gene, detected in two patients with X-linked chronic granulomatous disease |
| Q71131042 | A novel polymorphism in the coding region of CYBB, the human gp91-phox gene |
| Q45880406 | Advances in treatment for chronic granulomatous disease |
| Q30176967 | An SH3 domain-mediated interaction between the phagocyte NADPH oxidase factors p40phox and p47phox |
| Q43637658 | An intact cytoskeleton is required for prolonged respiratory burst activity during neutrophil phagocytosis |
| Q30176829 | Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase |
| Q43254303 | Atypical presentation of chronic granulomatous disease in an adolescent boy with frontal lobe located Aspergillus abscess mimicking intracranial tumor. |
| Q36130564 | CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells. |
| Q41825441 | Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease |
| Q35084276 | Chronic granulomatous disease: a review of the infectious and inflammatory complications |
| Q77344847 | Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice |
| Q35019838 | Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis |
| Q34508425 | Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. |
| Q35131029 | Current concepts of hyperinflammation in chronic granulomatous disease |
| Q41205789 | Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis |
| Q36367432 | Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease |
| Q43857344 | Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on N-formyl-methionyl-leucyl-phenylalanine-induced responses of polymorphonuclear neutrophils in vitro |
| Q41943463 | Evidence that the product of the human X-linked CGD gene, gp91-phox, is a voltage-gated H(+) pathway |
| Q34473374 | Gene therapy of chronic granulomatous disease: the engraftment dilemma |
| Q27007012 | Gene therapy on the move |
| Q35184193 | Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox). |
| Q37176109 | Genetics and immunopathology of chronic granulomatous disease |
| Q34094502 | Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease |
| Q28513571 | Granulocyte function in grancalcin-deficient mice |
| Q28291147 | Hematologically important mutations: X-linked chronic granulomatous disease (third update) |
| Q28593007 | Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G |
| Q38835840 | LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus |
| Q40526315 | Long-term interferon-gamma therapy for patients with chronic granulomatous disease |
| Q34660441 | McLeod syndrome: a neurohaematological disorder |
| Q77354724 | Modulation of the chemotactic peptide- and immunoglobulin G-triggered respiratory burst in human neutrophils by exogenous and endogenous adenosine |
| Q33654713 | Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients |
| Q36965983 | Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease |
| Q31883583 | Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes |
| Q35115451 | NADPH Oxidase in Endothelial Cells: Impact on Atherosclerosis |
| Q34092437 | NADPH oxidase-2 derived ROS dictates murine DC cytokine-mediated cell fate decisions during CD4 T helper-cell commitment |
| Q28511331 | Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways |
| Q74695645 | Oesophageal narrowing in chronic granulomatous disease |
| Q55048474 | Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China. |
| Q40921523 | Positional cloning and the molecular basis of immunodeficiency. |
| Q31033018 | Quantification of single nucleotide polymorphisms: a novel method that combines primer extension assay and capillary electrophoresis. |
| Q42609911 | Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. |
| Q27628646 | Structure of the TPR domain of p67phox in complex with Rac.GTP |
| Q90205330 | Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes |
| Q41096848 | The arachidonate-activatable, NADPH oxidase-associated H+ channel is contained within the multi-membrane-spanning N-terminal region of gp91-phox |
| Q28504676 | The p47phox mouse knock-out model of chronic granulomatous disease |
| Q71489260 | The serine protease inhibitor diisopropylfluorophosphate inhibits neutrophil NADPH-oxidase activity induced by the calcium ionophore ionomycin and serum opsonised yeast particles |
| Q28590403 | Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program |
| Q40900199 | Variegation of retroviral vector gene expression in myeloid cells |
| Q24683790 | Virulence factors of medically important fungi |
| Q34004078 | Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease |
| Q35952015 | p47(phox) directs murine macrophage cell fate decisions |
Search more.